These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18154744)
1. A cardiologist's perspective on cardiometabolic risk. Plutzky J Am J Cardiol; 2007 Dec; 100(12A):3P-6P. PubMed ID: 18154744 [TBL] [Abstract][Full Text] [Related]
2. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328 [TBL] [Abstract][Full Text] [Related]
3. The impact of the metabolic syndrome on the patients with acute coronary syndrome. Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271 [TBL] [Abstract][Full Text] [Related]
4. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785 [TBL] [Abstract][Full Text] [Related]
5. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults. Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513 [TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting. Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694 [TBL] [Abstract][Full Text] [Related]
8. The cardiometabolic syndrome in the adolescent. Gardner M; Gardner DW; Sowers JR Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711 [TBL] [Abstract][Full Text] [Related]
9. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients. Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P; J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723 [TBL] [Abstract][Full Text] [Related]
10. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Rizzo M; Rizvi AA; Rini GB; Berneis K Acta Diabetol; 2009 Mar; 46(1):1-11. PubMed ID: 18925358 [TBL] [Abstract][Full Text] [Related]
11. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803 [TBL] [Abstract][Full Text] [Related]
12. CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators? Després JP Int J Obes (Lond); 2008 May; 32 Suppl 2():S1-4. PubMed ID: 18469833 [No Abstract] [Full Text] [Related]
13. Cardiometabolic abnormalities in current National Football League players. Selden MA; Helzberg JH; Waeckerle JF; Browne JE; Brewer JH; Monaco ME; Tang F; O'Keefe JH Am J Cardiol; 2009 Apr; 103(7):969-71. PubMed ID: 19327424 [TBL] [Abstract][Full Text] [Related]
14. Use of the metabolic syndrome in pediatrics: a blessing and a curse. Battista M; Murray RD; Daniels SR Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755 [TBL] [Abstract][Full Text] [Related]
15. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Gao W; Int J Obes (Lond); 2008 May; 32(5):757-62. PubMed ID: 18209738 [TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632 [TBL] [Abstract][Full Text] [Related]
19. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
20. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]